Rheumatic heart disease (RHD) is a long-term consequence of rheumatic fever, an inflammatory disease that can develop after a strep throat or scarlet fever infection. When left untreated, the inflammation caused by rheumatic fever can damage the heart valves, leading to complications such as valve stenosis or regurgitation. While the disease was once common in many parts of the world, its prevalence has decreased significantly in developed countries due to widespread use of antibiotics to treat strep throat. However, RHD remains a major concern in low- and middle-income nations, where access to medical care and prevention programs is limited. Early detection and appropriate treatment of streptococcal throat infections are crucial in preventing the development of rheumatic heart disease.
Title : Pharmacological advancement in pulmonary arterial hypertension treatment - Contribution of treprostinil dry-powder formulation
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Personalized and Precision Medicine (PPM) and PPN-guided cardiology practice as a unique model via translational applications and upgraded business modeling to secure human healthcare, wellness and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibodies with functionality as a new generation of translational tools designed to monitor autoimmune myocarditis at clinical and subclinical stages
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation